Scarica l'app Stockscreener
6.69
1.04%
-0.07
Dopo l'orario di chiusura:
6.80
0.11
+1.64%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRVI Giù?
Forum
Previsione
Maravai Lifesciences Holdings Inc Borsa (MRVI) Ultime notizie
Maravai LifeSciences Holdings Inc (MRVI) Cash Flow - TradingKey
MRVI|Maravai LifeSciences Holdings Inc|Price:6.760|Chg%:-0.290 - TradingKey
TradingKey - TradingKey
Maravai LifeSciences Holdings Inc (MRVI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Maravai LifeSciences Holdings Inc (MRVI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Maravai Lifesciences Holdings, Inc. (MRVI) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Maravai Lifesciences Holdings, Inc. (MRVI) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Maravai LifeSciences(MRVI) Stock Options Chain | Quotes & News - Moomoo
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences - The National Law Review
Maravai LifeSciences to announce Q2 results on August 6 - scanx.trade
Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026 - Business Wire
Price to earnings forward of Maravai Lifesciences Holdings, Inc. Class A – FWB:MAR - TradingView
MRVI Secures New Patent for RNA Synthesis Technology - GuruFocus
TriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping Technology - Yahoo Finance
TriLink BioTechnologies Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap Capping Technology - Finviz
Maravai Lifesciences Holdings stock hits 52-week high at 7.1 USD - Investing.com Nigeria
Form 4 Maravai Lifesciences Holdings Inc For: 10 July By Investing.com - Investing.com Nigeria
Maravai Lifesciences (MRVI) CEO reports 29,250-share tax withholding event - Stock Titan
Maravai LifeSciences Announces Refinancing of Credit Agreement, Extending Maturity to 2032 - AOL.com
Maravai Q1 2026 slides: 41% revenue surge drives profitability return - Investing.com
Price to book forward of Maravai LifeSciences Holdings, Inc. – NASDAQ:MRVI - TradingView
Millennium Management LLC Reduces Stake in Maravai LifeSciences Holdings Inc - GuruFocus
MRVIMaravai LifeSciences Holdings Inc Volatility & Greeks - Finviz
Maravai LifeSciences stock. Identity holds, but no live catalyst is surfaced. - ad-hoc-news.de
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeScience - The National Law Review
Form 4 Maravai Lifesciences Holdings Inc For: 1 July By Investing.com - Investing.com Canada
Maravai (MRVI) CFO has 65,584 shares withheld for RSU tax - Stock Titan
Maravai LifeSciences (MRVI) Slips 3.83% as Stock Nears Critical Support AreaWatchlist Stock Ideas - DonanımHaber
Millennium Management reports >5% stake then falls below 5% in MRVI (MRVI) - Stock Titan
ETFs Investing in Maravai Lifesciences Holdings, Inc. Class A Stocks - TradingView
Price to earnings forward of Maravai Lifesciences Holdings, Inc. Class A – SWB:MAR - TradingView
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronste - The National Law Review
Maravai LifeSciences (MRVI) Investor presentation Summary - Quartr
Maravai Lifesciences Hits New 52-Week High at $5.42 - MarketsMojo
Maravai Lifesciences Hits New 52-Week High of $5.29, Marking Significant Milestone - MarketsMojo
MRVI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Maravai Lifesciences Hits New 52-Week High of $6.21 - MarketsMojo
Price to sales forward of Maravai LifeSciences Holdings, Inc. – NASDAQ:MRVI - TradingView
MAR Forecast — Price Target — Prediction for 2027 - TradingView
Maravai LifeSciences Holdings Inc (MRVI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Enterprise value to EBIT forward of Maravai LifeSciences Holdings, Inc. – NASDAQ:MRVI - TradingView
Maravai Lifesciences Holdings, Inc. Class A Actuals & Estimates (NASDAQ:MRVI) - TradingView
MRVI Forecast — Price Target — Prediction for 2027 - TradingView
Form 13G Maravai LifeSciences Holdings For: 23 June By Investing.com - Investing.com Australia
Millennium (MRVI) reports 7.32M shared stake, 4.96% as of Jun 16, 2026 - Stock Titan
Maravai LifeSciences Stockanalyst consensus and background snapshot - AD HOC NEWS
Maravai LifeSciences (MRVI) Holds Steady as Shares Consolidate Near Support LevelsPCR Moving Average - dars.gov.et
Maravai LifeSciences Holdings Inc (MRVI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Maravai LifeSciences Holdings Inc (MRVI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Maravai LifeSciences Holdings Inc (MRVI) Institutional Confidence - TradingKey
Maravai LifeSciences Holdings Inc (MRVI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
1.97%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):